REFERENCES: 
1. Ramírez E, Rossignoli T, Campos AJ, Muñoz R, Zegarra C, Tong H, Medrano N, Borobia AM, Carcas AJ, Frías J. Drug-induced life-threatening potassium disturbances detected by a pharmacovigilance program from laboratory signals. Eur J Clin Pharmacol. 2013 Jan;69(1):97-110. doi: 10.1007/s00228-012-1303-9. Epub 2012 May 31. PMID: 22648277. 2. Velázquez H, Perazella MA, Wright FS, Ellison DH. Renal mechanism of trimethoprim-induced hyperkalemia. Ann Intern Med. 1993 Aug 15;119(4):296-301. doi: 10.7326/0003-4819-119-4-199308150-00008. PMID: 8328738. 3. Al AdAwi RM, Albu-Mahmood Z, Abdelgelil M, Abdelaziz H, Stewart D, Awaisu A. Incidence of Co-Trimoxazole-Induced Hyperkalemia in a Tertiary Care Hospital. Risk Manag Healthc Policy. 2021;14:519-525. Published 2021 Feb 11. doi:10.2147/RMHP.S283471 4. Nickels LC, Jones C, Stead LG. Trimethoprim-sulfamethoxazole-induced hyperkalemia in a patient with normal renal function. Case Rep Emerg Med. 2012;2012:815907. doi: 10.1155/2012/815907. Epub 2012 Dec 13. PMID: 23326725; PMCID: PMC3542892. 5. Koç M, Bihorac A, Ozener CI, Kantarci G, Akoglu E. Severe hyperkalemia in two renal transplant recipients treated with standard dose of trimethoprim-sulfamethoxazole. Am J Kidney Dis. 2000 Sep;36(3):E18. doi: 10.1053/ajkd.2000.16220. PMID: 10977811. 6. More AS, Bhange NR, Gadekar KG, Kulkarni SG. Trimethoprim-induced hyperkalemia in renal transplant recipient. Indian J Transplant 2018;12:149-51. 7. Alappan R, Buller GK, Perazella MA. Trimethoprim-sulfamethoxazole therapy in outpatients: is hyperkalemia a significant problem? Am J Nephrol. 1999;19(3):389-94. doi: 10.1159/000013483. PMID: 10393376.